Trial Profile
A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 26 May 2014
Price :
$35
*
At a glance
- Drugs SiRNA 027 (Primary) ; Ranibizumab
- Indications Choroidal neovascularisation
- Focus Therapeutic Use
- Sponsors Allergan
- 26 May 2014 New trial record